Pozen, Inc. Announces Retirement Of Founder, Chairman And CEO Dr. John R. Plachetka; Adrian Adams Named As CEO

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to developing medicine that transforms lives, today announced that John R. Plachetka, Pharm.D., its founder, Chairman, Chief Executive Officer and President is retiring, effective immediately. Dr. Plachetka has also resigned from the Board of Directors of POZEN and has withdrawn as a nominee for election as a director at the 2015 Annual Meeting of Stockholders.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC